Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Baron

Showing results (51-60 of 281) with videos related to

Pageof 29
Sort By:
Arthritis and Rheumatism|April 29, 2008
Assessment of unmet needs and the lack of generalizability in the design of randomized controlled trials for scleroderma treatmentRenata Villela, Sai Yan Yuen, Janet E Pope, et al.
Arthritis Care & Research|April 19, 2022
Health Care Utilization in Systemic Sclerosis Patients With Digital UlcersTatiana Nevskaya, Leonardo M Calderon, Murray Baron, et al.
Journal of the American Academy of Dermatology|February 8, 2025
Usefulness of rituximab for the treatment of systemic sclerosis-associated interstitial lung disease: Further analysis of the DESIRES trialAi Kuzumi, Satoshi Ebata, Murray Baron, et al.
The Journal of Rheumatology|August 4, 2012
Longitudinal study of renal function in systemic sclerosisMelissa Caron, Marie Hudson, Murray Baron, et al.
Rheumatology International|July 26, 2012
Does cigarette smoking mitigate the severity of skin disease in systemic sclerosis?Geneviève Gyger, Marie Hudson, Ernest Lo, et al.
Arthritis and Rheumatism|April 3, 2008
Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosisBrett D Thombs, Marie Hudson, Suzanne S Taillefer, et al.
Journal of the American Academy of Dermatology|May 14, 2023
Organic solvent exposure and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group registryAnastasiya Muntyanu, Raymond Milan, Elham Rahme, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Special Issue "Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 2022"Barbara Ruaro, Murray Baron, Edoardo Rosato, et al.
The Journal of Rheumatology|May 17, 2013
Systemic sclerosis in Canada's North American Native population: assessment of clinical and serological manifestationsAdrienne Bacher, Shikha Mittoo, Marie Hudson, et al.
Clinical and Experimental Rheumatology|June 14, 2012
Best practices in scleroderma: an analysis of practice variability in SSc centres within the Canadian Scleroderma Research Group (CSRG)Sarah Harding, Sarit Khimdas, Ashley Bonner, et al.
Pageof 29

Showing results (51-60 of 281) with videos related to

Sort By:
Pageof 29
Arthritis and Rheumatism|April 29, 2008
Assessment of unmet needs and the lack of generalizability in the design of randomized controlled trials for scleroderma treatmentRenata Villela, Sai Yan Yuen, Janet E Pope, et al.
Arthritis Care & Research|April 19, 2022
Health Care Utilization in Systemic Sclerosis Patients With Digital UlcersTatiana Nevskaya, Leonardo M Calderon, Murray Baron, et al.
Journal of the American Academy of Dermatology|February 8, 2025
Usefulness of rituximab for the treatment of systemic sclerosis-associated interstitial lung disease: Further analysis of the DESIRES trialAi Kuzumi, Satoshi Ebata, Murray Baron, et al.
The Journal of Rheumatology|August 4, 2012
Longitudinal study of renal function in systemic sclerosisMelissa Caron, Marie Hudson, Murray Baron, et al.
Rheumatology International|July 26, 2012
Does cigarette smoking mitigate the severity of skin disease in systemic sclerosis?Geneviève Gyger, Marie Hudson, Ernest Lo, et al.
Arthritis and Rheumatism|April 3, 2008
Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosisBrett D Thombs, Marie Hudson, Suzanne S Taillefer, et al.
Journal of the American Academy of Dermatology|May 14, 2023
Organic solvent exposure and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group registryAnastasiya Muntyanu, Raymond Milan, Elham Rahme, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Special Issue "Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 2022"Barbara Ruaro, Murray Baron, Edoardo Rosato, et al.
The Journal of Rheumatology|May 17, 2013
Systemic sclerosis in Canada's North American Native population: assessment of clinical and serological manifestationsAdrienne Bacher, Shikha Mittoo, Marie Hudson, et al.
Clinical and Experimental Rheumatology|June 14, 2012
Best practices in scleroderma: an analysis of practice variability in SSc centres within the Canadian Scleroderma Research Group (CSRG)Sarah Harding, Sarit Khimdas, Ashley Bonner, et al.
Pageof 29